Together with the fact that SIRT3−/− and SIRT5−/− mice are susceptible to bacterial sepsis like wild-type mice (37–40), these observations strengthen the development of pharmacological modulators of the activity of mitochondrial sirtuins for clinical purposes. Here, SIRT3 is linked to bacterial infectious disease with sepsis.